TTK HEALTHCARE
Back to Cashflow Statement
|
TTK HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-22 Cr | ₹-12 Cr | ₹-10 Cr | ₹-17 Cr | ₹-10 Cr |
What is the latest Cash Flow from Financing Activities ratio of TTK HEALTHCARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-22 Cr |
Mar2023 | ₹-12 Cr |
Mar2022 | ₹-10 Cr |
Mar2021 | ₹-17 Cr |
Mar2020 | ₹-10 Cr |
How is Cash Flow from Financing Activities of TTK HEALTHCARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-22 Cr | Negative | |
Mar2023 | ₹-12 Cr | Negative | |
Mar2022 | ₹-10 Cr | Negative | |
Mar2021 | ₹-17 Cr | Negative | |
Mar2020 | ₹-10 Cr | - |
Compare Cash Flow from Financing Activities of peers of TTK HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TTK HEALTHCARE | ₹1,882.4 Cr | 0.2% | -6.6% | -8.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,400.0 Cr | 2% | -0.9% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,622.0 Cr | -1.6% | -0.4% | 57.3% | Stock Analytics | |
CIPLA | ₹116,240.0 Cr | -0.3% | -2.5% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,166.0 Cr | -0.5% | -3.3% | 14% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,495.2 Cr | -1% | 0.6% | 39.1% | Stock Analytics |
TTK HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TTK HEALTHCARE | 0.2% |
-6.6% |
-8.8% |
SENSEX | -0.4% |
-2.1% |
6.9% |
You may also like the below Video Courses